Cellaputics Bio
Cellapeutics Bio is a bio-venture company focused on the popularization of cell therapy through its innovative CELLA CON® platform, which utilizes somatic cell reprogramming technology. The company aims to reduce the costs and increase the efficacy of cell therapies, making them accessible to a broader population. Their key products include therapies for degenerative and intractable diseases, leveraging a unique combination of AI and omics-based drug development. With a commitment to improving the quality of life for patients suffering from severe conditions, Cellapeutics Bio positions itself as a leader in the global cell therapy market.
Cellaputics Bio
Cellapeutics Bio is a bio-venture company focused on the popularization of cell therapy through its innovative CELLA CON® platform, which utilizes somatic cell reprogramming technology. The company aims to reduce the costs and increase the efficacy of cell therapies, making them accessible to a broader population. Their key products include therapies for degenerative and intractable diseases, leveraging a unique combination of AI and omics-based drug development. With a commitment to improving the quality of life for patients suffering from severe conditions, Cellapeutics Bio positions itself as a leader in the global cell therapy market.